These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19465078)

  • 1. Identification of a novel dual E- and N-cadherin antagonist.
    Devemy E; Blaschuk OW
    Peptides; 2009 Aug; 30(8):1539-47. PubMed ID: 19465078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel N-cadherin antagonist.
    Devemy E; Blaschuk OW
    Peptides; 2008 Nov; 29(11):1853-61. PubMed ID: 18655820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel peptide mimetic small molecules of the HAV motif in N-cadherin inhibit N-cadherin-mediated neurite outgrowth and cell adhesion.
    Burden-Gulley SM; Gates TJ; Craig SE; Lou SF; Oblander SA; Howell S; Gupta M; Brady-Kalnay SM
    Peptides; 2009 Dec; 30(12):2380-7. PubMed ID: 19765627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
    Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
    Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fusion protein N-cadherin-Fc as an artificial extracellular matrix surface for maintenance of stem cell features.
    Yue XS; Murakami Y; Tamai T; Nagaoka M; Cho CS; Ito Y; Akaike T
    Biomaterials; 2010 Jul; 31(20):5287-96. PubMed ID: 20398934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A peptidomimetic antagonist of TNF-alpha-mediated cytotoxicity identified from a phage-displayed random peptide library.
    Chirinos-Rojas CL; Steward MW; Partidos CD
    J Immunol; 1998 Nov; 161(10):5621-6. PubMed ID: 9820541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INP, a novel N-cadherin antagonist targeted to the amino acids that flank the HAV motif.
    Williams EJ; Williams G; Gour B; Blaschuk O; Doherty P
    Mol Cell Neurosci; 2000 May; 15(5):456-64. PubMed ID: 10833302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody recognition of peptide sequences from the cell-cell adhesion proteins: N- and E-cadherins.
    Lutz KL; Szabo LA; Thompson DL; Siahaan TJ
    Pept Res; 1996; 9(5):233-9. PubMed ID: 9000249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of N-cadherin-dependent neurite outgrowth by small molecule peptide mimetic agonists of the N-cadherin HAV motif.
    Burden-Gulley SM; Gates TJ; Craig SE; Gupta M; Brady-Kalnay SM
    Peptides; 2010 May; 31(5):842-9. PubMed ID: 20153391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of antibiotic clarithromycin binding peptide displayed by T7 phage particles.
    Morimura T; Noda N; Kato Y; Watanabe T; Saitoh T; Yamazaki T; Takada K; Aoki S; Ohta K; Ohshige M; Sakaguchi K; Sugawara F
    J Antibiot (Tokyo); 2006 Oct; 59(10):625-32. PubMed ID: 17191677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and development of N-cadherin antagonists.
    Blaschuk OW
    Cell Tissue Res; 2012 May; 348(2):309-13. PubMed ID: 22281688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of e-cadherin-mediated homotypic adhesion of Caco-2 cells: a novel evaluation assay for peptide activities in modulating cell-cell adhesion.
    Kobayashi N; Ikesue A; Majumdar S; Siahaan TJ
    J Pharmacol Exp Ther; 2006 Apr; 317(1):309-16. PubMed ID: 16371447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening peptides binding specifically to large intestinal cancer LoVo cells from phage random peptide library].
    Liao KX; Yao XQ; Wu CT; Lin F; Wu WL; Zeng SD; Luo YQ; Lei ST
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):986-90. PubMed ID: 18583245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmin produces an E-cadherin fragment that stimulates cancer cell invasion.
    Ryniers F; Stove C; Goethals M; Brackenier L; Noë V; Bracke M; Vandekerckhove J; Mareel M; Bruyneel E
    Biol Chem; 2002 Jan; 383(1):159-65. PubMed ID: 11928810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peptide-based carrier for intracellular delivery of proteins into malignant glial cells in vitro.
    Wu C; Lo SL; Boulaire J; Hong ML; Beh HM; Leung DS; Wang S
    J Control Release; 2008 Sep; 130(2):140-5. PubMed ID: 18632177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cadherin engagement protects human β-cells from apoptosis.
    Parnaud G; Gonelle-Gispert C; Morel P; Giovannoni L; Muller YD; Meier R; Borot S; Berney T; Bosco D
    Endocrinology; 2011 Dec; 152(12):4601-9. PubMed ID: 21990317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An FcgammaRIIa-binding peptide that mimics the interaction between FcgammaRIIa and IgG.
    Cendron AC; Wines BD; Brownlee RT; Ramsland PA; Pietersz GA; Hogarth PM
    Mol Immunol; 2008 Jan; 45(2):307-19. PubMed ID: 17673295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary structure of the HAV peptide which regulates cadherin-cadherin interaction.
    Lutz KL; Jois SD; Siahaan TJ
    J Biomol Struct Dyn; 1995 Dec; 13(3):447-55. PubMed ID: 8825724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different Ca2+ affinities and functional implications of the two synaptic adhesion molecules cadherin-11 and N-cadherin.
    Heupel WM; Baumgartner W; Laymann B; Drenckhahn D; Golenhofen N
    Mol Cell Neurosci; 2008 Mar; 37(3):548-58. PubMed ID: 18201900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cadherins as novel targets for anti-cancer therapy.
    Blaschuk OW; Devemy E
    Eur J Pharmacol; 2009 Dec; 625(1-3):195-8. PubMed ID: 19836380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.